Nearly 12 million bottles of Rohto eye drops over sterility concerns, FDA announces

The FDA has recalled nearly 12 million bottles of Rohto eye drops due to potential sterility issues. The FDA has not yet specified the exact nature of the sterility concerns or the timeline for the issue's discovery. The recall spans multiple states, with local outlets like mynbc15.com and patch.com providing regional guidance. The eye drops in question are marketed for their cooling effect, adding to consumer confusion and concern.

The FDA's announcement has triggered widespread reporting, with outlets like Fox Business and Prevention focusing on the nationwide impact. The News Journal specifies that prescription eye drops are also affected, though details on the specific prescriptions remain unclear. The recall's scope and the specific batches affected vary across reports. mynbc15.com and WSMH both mention over 12 million bottles, while EatingWell specifies over 11 million. The discrepancy in numbers adds to the uncertainty.

The FDA has not yet released a comprehensive list of affected batches or expiration dates, leaving consumers to rely on general recall notices. The immediate health risks and long-term implications of the recall are still unknown. The FDA has not specified whether any adverse events have been reported due to the sterility concerns. Consumers are advised to check their eye drop bottles against the recall information provided by the FDA and to consult healthcare providers if they have used the affected products.